MMIRF (MedMira) Total Liabilities: $20.05 Mil (As of Jan. 2026)


What is MedMira Total Liabilities?

MedMira MMIRF +302.48% Total Liabilities is $20.05 Mil as of Jan. 2026. The stock has 6 warning signs investors should review.

MedMira's Total Liabilities for the quarter that ended in Jan. 2026 was $20.05 Mil.

MedMira's quarterly Total Liabilities increased from Jul. 2025 ($19.17 Mil) to Oct. 2025 ($19.28 Mil) and increased from Oct. 2025 ($19.28 Mil) to Jan. 2026 ($20.05 Mil).

MedMira's annual Total Liabilities increased from Jul. 2023 ($14.14 Mil) to Jul. 2024 ($17.58 Mil) and increased from Jul. 2024 ($17.58 Mil) to Jul. 2025 ($19.17 Mil).


MedMira Total Liabilities Historical Data

* Premium members only.

The historical data trend for MedMira's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira Total Liabilities Chart

MedMira Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.65 12.51 14.14 17.58 19.17

MedMira Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.19 18.09 19.17 19.28 20.05

MedMira Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MedMira's Total Liabilities for the fiscal year that ended in Jul. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=16.082+(3.086+-1.3322676295502E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=19.17

Total Liabilities=Total Assets (A: Jul. 2025 )-Total Equity (A: Jul. 2025 )
=2.689--16.479
=19.17

MedMira's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=18.25+(1.799+-4.4408920985006E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=20.05

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=2.598--17.451
=20.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $20.05 Mil mean?
MedMira (MMIRF) has a Total Liabilities of $20.05 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MedMira and its competitors.
Is MedMira's Total Liabilities too high?
MedMira's current Total Liabilities is $20.05 Mil.
How does MedMira's Total Liabilities compare to VRTX and REGN?
MedMira's Total Liabilities of $20.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MedMira and its competitors. MedMira's current Total Liabilities is $20.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMira stock overvalued right now?
MedMira (MMIRF) has a current Total Liabilities of $20.05 Mil. The current Total Liabilities is $20.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For MedMira (MMIRF), the current Total Liabilities is $20.05 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMira Business Description

Other Exchanges MIR:Canada
Address 155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.